Hambrecht & Quist Capital Management
Latest statistics and disclosures from Tekla Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are GILD, AMGN, VRTX, JNJ, BIIB, and represent 26.84% of Tekla Capital Management's stock portfolio.
- Added to shares of these 10 stocks: BIIB (+$15.06M), CNC (+$8.24M), MRNA (+$7.61M), LLY (+$6.73M), SNY (+$6.15M), CERN (+$5.13M), IQV (+$5.01M), WAT, BMY, SYK.
- Started 14 new stock positions in MNLO, FVE, AXSM, KOD, BLCM, EXAS, NHI, HALO, VIE, WAT. MNTA, GRFS, MRNA, CERN.
- Reduced shares in these 10 stocks: REGN (-$14.84M), MRK (-$14.53M), Medicines Company (-$10.25M), JNJ (-$10.24M), PFE (-$8.65M), CI (-$8.49M), ANTM (-$8.28M), SGEN (-$7.18M), , UNH (-$5.49M).
- Sold out of its positions in ADAP, ArQule, Bellicum Pharma, Dermira, IBB, MASI, Medicines Company, MYGN, XBI, XENE. Foamix Pharmaceuticals Ltd shs.
- Tekla Capital Management was a net seller of stock by $82.96M.
- Tekla Capital Management has $2.21B in assets under management (AUM), dropping by -16.34%.
Portfolio Holdings for Tekla Capital Management
Companies in the Tekla Capital Management portfolio as of the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Share Count | Change in Shares | Price |
|---|---|---|---|---|
| Gilead Sciences (GILD) | 6.38 | 1.89M | 74.76 | |
| Amgen (AMGN) | 5.50 | 599.87k | -2% | 202.73 |
| Vertex Pharmaceuticals Incorporated (VRTX) | 5.22 | 485.73k | 237.95 | |
| Johnson & Johnson (JNJ) | 4.97 | 838.77k | -8% | 131.13 |
| Biogen Idec (BIIB) | 4.76 | 332.74k | +16% | 316.38 |
| Regeneron Pharmaceuticals (REGN) | 3.77 | 170.88k | -15% | 488.29 |
| Merck & Co (MRK) | 3.56 | 1.02M | -15% | 76.94 |
| Illumina (ILMN) | 3.28 | 265.32k | -2% | 273.12 |
| Pfizer (PFE) | 2.69 | 1.82M | -12% | 32.64 |
| UnitedHealth (UNH) | 2.56 | 226.83k | -8% | 249.38 |
| Bristol Myers Squibb (BMY) | 2.13 | 844.93k | +9% | 55.74 |
| Medtronic (MDT) | 1.82 | 447.01k | -5% | 90.18 |
| Alexion Pharmaceuticals (ALXN) | 1.68 | 413.33k | -5% | 89.79 |
| Abbott Laboratories (ABT) | 1.66 | 466.55k | 78.91 | |
| Eli Lilly & Co. (LLY) | 1.62 | 258.67k | +23% | 138.72 |
| Thermo Fisher Scientific (TMO) | 1.44 | 112.03k | -9% | 283.60 |
| Incyte Corporation (INCY) | 1.43 | 432.25k | +12% | 73.23 |
| CVS Caremark Corporation (CVS) | 1.34 | 497.99k | 59.33 | |
| Allergan | 1.26 | 157.98k | 177.10 | |
| Abbvie (ABBV) | 1.17 | 340.92k | 76.19 | |
| Cigna Corp (CI) | 1.14 | 142.66k | -25% | 177.18 |
| Seattle Genetics (SGEN) | 1.12 | 214.53k | -22% | 115.38 |
| BioMarin Pharmaceutical (BMRN) | 1.03 | 270.61k | -2% | 84.50 |
| Stryker Corporation (SYK) | 1.02 | 135.79k | +19% | 166.49 |
| Danaher Corporation (DHR) | 1.00 | 159.35k | -3% | 138.41 |
| Boston Scientific Corporation (BSX) | 0.87 | 587.66k | +4% | 32.63 |
| Zoetis Inc Cl A (ZTS) | 0.81 | 151.95k | -20% | 117.69 |
| Becton, Dickinson and (BDX) | 0.81 | 77.75k | +17% | 229.78 |
| Neurocrine Biosciences (NBIX) | 0.81 | 206.15k | +6% | 86.55 |
| Centene Corporation (CNC) | 0.77 | 288.19k | +92% | 59.41 |
| Intuitive Surgical (ISRG) | 0.76 | 34.04k | -12% | 495.20 |
| Mylan Nv (MYL) | 0.68 | 1.01M | -2% | 14.91 |
| Alnylam Pharmaceuticals (ALNY) | 0.68 | 137.62k | -4% | 108.85 |
| Anthem (ANTM) | 0.67 | 65.57k | -35% | 227.05 |
| Novartis (NVS) | 0.67 | 179.85k | -14% | 82.45 |
| Humana (HUM) | 0.65 | 46.13k | -16% | 314.03 |
| Sanofi-Aventis SA (SNY) | 0.65 | 327.37k | +75% | 43.72 |
| Sarepta Therapeutics (SRPT) | 0.62 | 140.13k | -22% | 97.82 |
| Edwards Lifesciences (EW) | 0.57 | 67.38k | -3% | 188.63 |
| AstraZeneca (AZN) | 0.56 | 276.10k | 44.66 | |
| Pra Health Sciences (PRAH) | 0.54 | 143.51k | -6% | 83.04 |
| Horizon Therapeutics (HZNP) | 0.53 | 399.26k | +31% | 29.62 |
| Bio-techne Corporation (TECH) | 0.49 | 57.69k | +15% | 189.61 |
| IDEXX Laboratories (IDXX) | 0.44 | 40.31k | -7% | 242.25 |
| ACADIA Pharmaceuticals (ACAD) | 0.42 | 221.60k | 42.25 | |
| Welltower Inc Com reit (WELL) | 0.42 | 203.08k | +5% | 45.78 |
| Beigene (BGNE) | 0.42 | 74.98k | -7% | 123.11 |
| Ionis Pharmaceuticals (IONS) | 0.41 | 193.20k | -7% | 47.28 |
| Iqvia Holdings (IQV) | 0.40 | 82.27k | +129% | 107.86 |
| Exelixis (EXEL) | 0.40 | 515.12k | 17.22 | |
| Blueprint Medicines (BPMC) | 0.37 | 139.34k | +19% | 58.48 |
| Omega Healthcare Investors (OHI) | 0.37 | 306.43k | +7% | 26.54 |
| Novo Nordisk A/S (NVO) | 0.36 | 134.00k | -39% | 60.20 |
| McKesson Corporation (MCK) | 0.36 | 59.52k | -11% | 135.25 |
| Zimmer Holdings (ZBH) | 0.36 | 78.17k | +22% | 101.08 |
| Baxter International (BAX) | 0.36 | 97.18k | -25% | 81.19 |
| GlaxoSmithKline (GSK) | 0.35 | 206.87k | -19% | 37.89 |
| Ascendis Pharma A S (ASND) | 0.35 | 69.33k | 112.60 | |
| Moderna (MRNA) | 0.34 | 254.15k | NEW | 29.95 |
| HCA HOLDINGS (HCA) | 0.34 | 83.83k | -12% | 89.85 |
| Novocure Ltd ord (NVCR) | 0.33 | 107.44k | 67.34 | |
| Medical Properties Trust (MPW) | 0.32 | 411.74k | +10% | 17.29 |
| Teva Pharmaceutical Industries (TEVA) | 0.32 | 785.85k | 8.98 | |
| Physicians Realty Trust (DOC) | 0.31 | 495.73k | +8% | 13.94 |
| Fibrogen (FGEN) | 0.31 | 194.27k | 34.75 | |
| Jazz Pharmaceuticals (JAZZ) | 0.30 | 67.46k | -21% | 99.74 |
| Agios Pharmaceuticals (AGIO) | 0.30 | 186.96k | -13% | 35.48 |
| Iovance Biotherapeutics (IOVA) | 0.30 | 221.07k | -9% | 29.94 |
| Immunomedics (IMMU) | 0.30 | 487.10k | 13.48 | |
| Sutro Biopharma (STRO) | 0.30 | 641.27k | 10.20 | |
| Mirati Therapeutics (MRTX) | 0.27 | 78.78k | +11% | 76.87 |
| Global Blood Therapeutics In (GBT) | 0.27 | 118.08k | -19% | 51.09 |
| United Therapeutics Corporation (UTHR) | 0.27 | 63.51k | +17% | 94.83 |
| Argenx Se (ARGX) | 0.27 | 44.98k | 131.73 | |
| Atreca Inc Cl A (BCEL) | 0.26 | 352.42k | -32% | 16.55 |
| LTC Properties (LTC) | 0.25 | 182.29k | +10% | 30.90 |
| Rts/bristol-myers Squibb Compa (BMY.R) | 0.25 | 1.47M | 3.80 | |
| Ventas (VTR) | 0.25 | 208.11k | +8% | 26.80 |
| Sabra Health Care REIT (SBRA) | 0.25 | 510.66k | +9% | 10.92 |
| Ptc Therapeutics I (PTCT) | 0.24 | 120.83k | +21% | 44.61 |
| Zogenix (ZGNX) | 0.24 | 215.41k | +100% | 24.73 |
| Theravance Biopharma (TBPH) | 0.24 | 228.84k | +94% | 23.11 |
| Cerner Corporation (CERN) | 0.23 | 81.50k | NEW | 62.99 |
| Reata Pharmaceuticals Inc Cl A (RETA) | 0.23 | 35.13k | +33% | 144.35 |
| Teleflex Incorporated (TFX) | 0.23 | 17.25k | +10% | 292.84 |
| AmerisourceBergen (ABC) | 0.22 | 54.11k | -53% | 88.49 |
| Allogene Therapeutics (ALLO) | 0.21 | 244.26k | +204% | 19.44 |
| Waters Corporation (WAT) | 0.21 | 26.00k | NEW | 182.04 |
| Nektar Therapeutics (NKTR) | 0.21 | 263.08k | -7% | 17.85 |
| Apellis Pharmaceuticals (APLS) | 0.21 | 173.49k | +32% | 26.79 |
| Flamel Technologies Sa (AVDL) | 0.20 | 566.07k | -30% | 7.94 |
| Dentsply Sirona (XRAY) | 0.20 | 114.74k | -4% | 38.83 |
| Xencor (XNCR) | 0.20 | 148.23k | 29.88 | |
| Gw Pharmaceuticals Plc ads (GWPH) | 0.20 | 50.10k | 87.56 | |
| Ultragenyx Pharmaceutical (RARE) | 0.20 | 97.48k | 44.43 | |
| ABIOMED (ABMD) | 0.19 | 29.52k | -9% | 145.18 |
| Syneos Health (SYNH) | 0.19 | 108.00k | -6% | 39.42 |
| Mettler-Toledo International (MTD) | 0.19 | 6.12k | +44% | 690.51 |
| Laboratory Corp. of America Holdings (LH) | 0.18 | 31.42k | 126.40 | |
| Galera Therapeutics (GRTX) | 0.18 | 416.67k | 9.50 | |
| Bluebird Bio (BLUE) | 0.17 | 84.19k | -12% | 45.97 |
| Agilent Technologies Inc C ommon (A) | 0.17 | 52.52k | +92% | 71.62 |
| Fate Therapeutics (FATE) | 0.17 | 165.67k | 22.21 | |
| Acceleron Pharma (XLRN) | 0.16 | 40.61k | -52% | 89.86 |
| Peak (PEAK) | 0.16 | 150.39k | +17% | 23.85 |
| Smith & Nephew (SNN) | 0.16 | 99.56k | 35.87 | |
| Ardelyx (ARDX) | 0.16 | 607.70k | 5.69 | |
| Amicus Therapeutics (FOLD) | 0.15 | 368.96k | 9.24 | |
| Pieris Pharmaceuticals (PIRS) | 0.15 | 1.45M | 2.28 | |
| Crispr Therapeutics (CRSP) | 0.15 | 76.22k | 42.42 | |
| Epizyme (EPZM) | 0.15 | 207.75k | -41% | 15.51 |
| Takeda Pharmaceutical (TAK) | 0.14 | 210.15k | 15.18 | |
| Genmab A/s -sp (GMAB) | 0.14 | 148.15k | +796% | 21.19 |
| Healthcare Realty Trust Incorporated (HR) | 0.13 | 104.02k | +24% | 27.93 |
| PerkinElmer (PKI) | 0.13 | 38.49k | +102% | 75.28 |
| Rocket Pharmaceuticals (RCKT) | 0.13 | 207.56k | 13.95 | |
| Allakos (ALLK) | 0.13 | 64.40k | -9% | 44.49 |
| Sage Therapeutics (SAGE) | 0.12 | 96.21k | 28.72 | |
| Inogen (INGN) | 0.12 | 51.41k | 51.67 | |
| ResMed (RMD) | 0.12 | 17.83k | -35% | 147.27 |
| Editas Medicine (EDIT) | 0.12 | 130.20k | -11% | 19.83 |
| Deciphera Pharmaceuticals (DCPH) | 0.11 | 61.37k | 41.18 | |
| Momenta Pharmaceuticals (MNTA) | 0.11 | 91.32k | NEW | 27.20 |
| Alkermes (ALKS) | 0.11 | 169.93k | -14% | 14.42 |
| Amarin Corporation (AMRN) | 0.11 | 603.79k | +47% | 4.00 |
| Acadia Healthcare (ACHC) | 0.11 | 131.20k | -3% | 18.35 |
| Charles River Laboratories (CRL) | 0.11 | 18.47k | -11% | 126.23 |
| Koninklijke Philips Electronics NV (PHG) | 0.10 | 55.80k | +30% | 40.16 |
| Ligand Pharmaceuticals In (LGND) | 0.10 | 30.59k | -25% | 72.74 |
| Intercept Pharmaceuticals In (ICPT) | 0.10 | 34.41k | 62.97 | |
| Arrowhead Pharmaceuticals (ARWR) | 0.10 | 74.19k | -29% | 28.77 |
| Uniqure Nv (QURE) | 0.09 | 43.85k | -38% | 47.46 |
| Y Mabs Therapeutics (YMAB) | 0.09 | 76.55k | +575% | 26.10 |
| Endo International (ENDP) | 0.09 | 531.57k | 3.70 | |
| Zai Lab (ZLAB) | 0.09 | 37.52k | 51.49 | |
| Alcon (ALC) | 0.08 | 36.69k | -33% | 50.81 |
| Axsome Therapeutics (AXSM) | 0.08 | 31.59k | NEW | 58.81 |
| Bausch Health Companies (BHC) | 0.08 | 118.41k | -14% | 15.50 |
| Coherus Biosciences (CHRS) | 0.08 | 111.66k | -10% | 16.22 |
| Trillium Therapeutics, Inc. Cmn (TRIL) | 0.08 | 448.05k | 4.04 | |
| Global Medical Reit (GMRE) | 0.08 | 174.90k | +48% | 10.12 |
| Align Technology (ALGN) | 0.08 | 10.04k | -55% | 173.99 |
| Ra Pharmaceuticals | 0.08 | 35.74k | -35% | 48.01 |
| Healthcare Tr Amer Inc cl a (HTA) | 0.08 | 70.66k | +53% | 24.28 |
| Quest Diagnostics Incorporated (DGX) | 0.08 | 21.02k | 80.29 | |
| Anaptysbio Inc Common (ANAB) | 0.08 | 118.26k | 14.13 | |
| Guardant Health (GH) | 0.07 | 23.66k | +445% | 69.58 |
| Insmed (INSM) | 0.07 | 98.39k | -40% | 16.03 |
| Steris Plc Ord equities (STE) | 0.07 | 11.22k | -24% | 139.95 |
| Heron Therapeutics (HRTX) | 0.07 | 131.18k | +119% | 11.74 |
| Biohaven Pharmaceutical Holding (BHVN) | 0.07 | 45.16k | +55% | 34.03 |
| Pacific Biosciences of California (PACB) | 0.07 | 495.50k | 3.06 | |
| Intra Cellular Therapies (ITCI) | 0.07 | 94.24k | 15.37 | |
| Tenet Healthcare Corporation (THC) | 0.06 | 96.74k | -14% | 14.40 |
| Medpace Hldgs (MEDP) | 0.06 | 18.87k | 73.39 | |
| Healthequity (HQY) | 0.06 | 27.31k | -14% | 50.60 |
| EXACT Sciences Corporation (EXAS) | 0.06 | 23.13k | NEW | 58.01 |
| Aurinia Pharmaceuticals (AUPH) | 0.06 | 90.79k | 14.51 | |
| Esperion Therapeutics (ESPR) | 0.06 | 41.58k | -80% | 31.53 |
| Diversified Healthcare Trust (DHC) | 0.06 | 357.72k | 3.63 | |
| Galapagos Nv-spon (GLPG) | 0.06 | 6.54k | 195.93 | |
| Revance Therapeutics (RVNC) | 0.06 | 85.84k | 14.79 | |
| Halozyme Therapeutics (HALO) | 0.06 | 69.92k | NEW | 17.99 |
| Evolent Health (EVH) | 0.06 | 231.03k | 5.43 | |
| Wave Life Sciences (WVE) | 0.05 | 128.15k | +28% | 9.37 |
| Ac Immune Sa (ACIU) | 0.05 | 171.81k | 6.91 | |
| Arena Pharmaceuticals (ARNA) | 0.05 | 28.00k | 42.00 | |
| Avrobio Ord (AVRO) | 0.05 | 74.87k | 15.56 | |
| Hologic (HOLX) | 0.05 | 32.56k | -23% | 35.10 |
| Bridgebio Pharma (BBIO) | 0.05 | 39.23k | 29.01 | |
| Universal Health Realty Income Trust (UHT) | 0.05 | 11.26k | +96% | 100.82 |
| Ovid Therapeutics (OVID) | 0.05 | 372.73k | 2.98 | |
| Kodiak Sciences (KOD) | 0.05 | 23.15k | NEW | 47.68 |
| Verona Pharma Plc ads (VRNA) | 0.05 | 253.18k | -7% | 4.12 |
| Quotient (QTNT) | 0.05 | 260.03k | 3.95 | |
| Cellectis S A (CLLS) | 0.05 | 110.15k | 9.20 | |
| Eidos Therapeutics (EIDX) | 0.04 | 20.00k | 49.00 | |
| Grifols S A Sponsored Adr R (GRFS) | 0.04 | 47.37k | NEW | 20.14 |
| Sangamo Biosciences (SGMO) | 0.04 | 149.84k | 6.37 | |
| Myokardia (MYOK) | 0.04 | 19.30k | 46.89 | |
| Aerie Pharmaceuticals (AERI) | 0.04 | 66.69k | 13.50 | |
| Madrigal Pharmaceuticals (MDGL) | 0.04 | 13.34k | 66.79 | |
| Health Care SPDR (XLV) | 0.04 | 10.05k | -81% | 88.61 |
| Portola Pharmaceuticals (PTLA) | 0.04 | 109.25k | -32% | 7.13 |
| Axonics Modulation Technolog (AXNX) | 0.03 | 28.10k | 25.41 | |
| Regenxbio Inc equity us cm (RGNX) | 0.03 | 21.70k | -38% | 32.40 |
| Rubius Therapeutics (RUBY) | 0.03 | 155.98k | +128% | 4.45 |
| Intellia Therapeutics (NTLA) | 0.03 | 55.05k | 12.23 | |
| New Senior Inv Grp (SNR) | 0.03 | 256.40k | +62% | 2.56 |
| Puma Biotechnology (PBYI) | 0.03 | 71.34k | 8.44 | |
| ImmunoGen (IMGN) | 0.03 | 168.19k | 3.41 | |
| Community Healthcare Tr (CHCT) | 0.03 | 14.90k | 38.26 | |
| Molecular Templates (MTEM) | 0.03 | 42.31k | 13.28 | |
| Zymeworks (ZYME) | 0.02 | 15.19k | 35.48 | |
| Perrigo Company (PRGO) | 0.02 | 10.82k | 48.07 | |
| National Health Investors (NHI) | 0.02 | 10.04k | NEW | 49.51 |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.02 | 195.26k | +22% | 2.48 |
| Menlo Therapeutics (MNLO) | 0.02 | 178.18k | NEW | 2.68 |
| Morphosys (MOR) | 0.02 | 19.39k | 24.55 | |
| Community Health Systems (CYH) | 0.02 | 117.73k | -42% | 3.34 |
| Milestone Pharmaceuticals (MIST) | 0.02 | 213.31k | -71% | 1.84 |
| Novavax (NVAX) | 0.02 | 28.55k | 13.59 | |
| Clearside Biomedical (CLSD) | 0.01 | 165.33k | 1.70 | |
| Spectrum Pharmaceuticals (SPPI) | 0.01 | 114.67k | 2.33 | |
| Merus N V (MRUS) | 0.01 | 21.21k | 12.11 | |
| Turning Point Therapeutics I (TPTX) | 0.01 | 5.68k | 44.74 | |
| Aerpio Pharmaceuticals (ARPO) | 0.01 | 257.55k | 0.55 | |
| Cymabay Therapeutics (CBAY) | 0.01 | 88.10k | 1.48 | |
| Magenta Therapeutics (MGTA) | 0.00 | 16.76k | 6.27 | |
| Arca Biopharma (ABIO) | 0.00 | 36.07k | 2.77 | |
| Five Star Senior (FVE) | 0.00 | 24.24k | NEW | 2.76 |
| Mallinckrodt Pub (MNK) | 0.00 | 32.98k | 1.97 | |
| Tetraphase Pharms (TTPH) | 0.00 | 42.97k | 1.28 | |
| Bellicum Pharmaceuticals (BLCM) | 0.00 | 6.00k | NEW | 4.67 |
| Viela Bio (VIE) | 0.00 | 500 | NEW | 38.00 |
| Celldex Therapeutics (CLDX) | 0.00 | 7.05k | 1.70 | |
| Quorum Health (QHCCQ) | 0.00 | 23.73k | 0.46 |
Download CSV 
Past Filings by Tekla Capital Management
View past SEC 13F filings by Tekla Capital Management
- Tekla Capital Management 2019 Q4 filed Feb. 13, 2020
- Tekla Capital Management 2019 Q3 filed Nov. 13, 2019
- Tekla Capital Management 2019 Q1 filed May 14, 2019
- Tekla Capital Management 2018 Q4 filed Feb. 13, 2019
- Tekla Capital Management 2018 Q3 filed Nov. 13, 2018
- Tekla Capital Management 2018 Q2 filed Aug. 13, 2018
- Tekla Capital Management 2018 Q1 filed May 14, 2018
- Tekla Capital Management 2017 Q4 filed Feb. 14, 2018
- Tekla Capital Management 2017 Q3 filed Nov. 13, 2017
- Tekla Capital Management 2017 Q2 filed Aug. 14, 2017
- Tekla Capital Management 2017 Q1 filed May 12, 2017
- Tekla Capital Management 2016 Q4 filed Feb. 13, 2017
- Tekla Capital Management 2016 Q3 filed Nov. 14, 2016
- Tekla Capital Management 2016 Q2 filed Aug. 12, 2016
- Tekla Capital Management 2016 Q1 filed May 9, 2016
- Tekla Capital Management 2015 Q4 filed Feb. 9, 2016
- Tekla Capital Management 2015 Q3 filed Nov. 13, 2015
- Tekla Capital Management 2015 Q2 filed Aug. 12, 2015
- Tekla Capital Management 2015 Q1 filed May 6, 2015